Skip to main content
OpenTrials

Clinical trial condition

Leukemia, Lymphocytic, Chronic, B-Cell

Explore clinical trials studying Leukemia, Lymphocytic, Chronic, B-Cell. Study availability and eligibility vary by location and protocol.

1,434 public trials 165 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, Lymphocytic, Chronic, B-Cell trial results

Active, Not Recruiting

A Study to Customize Ibrutinib Treatment Regimens for Participants With Previously Untreated Chronic Lymphocytic Leukemia

NCT05963074

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +14 more
Locations
  • The Oncology Institute Clinical Research Cerritos, California, United States
  • Cancer and Blood Specialty Clinic Los Alamitos, California, United States
  • SLO Oncology and Hematology Health Center San Luis Obispo, California, United States
  • Providence Medical Foundation Santa Rosa, California, United States
View all 74 locations
View Trial Details
Active, Not Recruiting

Ibrutinib and Rituximab Compared With Fludarabine Phosphate, Cyclophosphamide, and Rituximab in Treating Patients With Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

NCT02048813

Conditions
Anemia, Chronic Disease, Chronic Lymphocytic Leukemia, +16 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
View all 782 locations
View Trial Details
Active, Not Recruiting

A Study of JNJ-80948543, a T-cell Redirecting CD79b x CD20 x CD3 Trispecific Antibody, in Participants With Non-Hodgkin Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL)

NCT05424822

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +15 more
Locations
  • City of Hope Duarte, California, United States
  • Icahn School of Medicine at Mount Sinai New York, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
  • Sarah Cannon Research Institute Nashville, Tennessee, United States
View all 29 locations
View Trial Details
Active, Not Recruiting

A Study of Zilovertamab Vedotin (MK-2140) as Monotherapy and in Combination in Participants With Aggressive and Indolent B-cell Malignancies (MK-2140-006)

NCT05458297

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +21 more
Locations
  • Alaska Oncology and Hematology ( Site 0037) Anchorage, Alaska, United States
  • Banner MD Anderson Cancer Center ( Site 0040) Gilbert, Arizona, United States
  • Banner MD Anderson Cancer Center - University Medical Center Phoenix-Medical Oncology ( Site 0036) Phoenix, Arizona, United States
  • University of Colorado Anschutz Medical Campus-The Center for Cancer and Blood Disorders ( Site 0008) Aurora, Colorado, United States
View all 108 locations
View Trial Details
Active, Not Recruiting

Multi-antigen CMV-MVA Triplex Vaccine in Reducing CMV Complications in Patients Previously Infected With CMV and Undergoing Donor Hematopoietic Cell Transplant

NCT02506933

Conditions
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission, +43 more
Locations
  • City of Hope Medical Center Duarte, California, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • M D Anderson Cancer Center Houston, Texas, United States
View Trial Details
Active, Not Recruiting

Study to Evaluate Adverse Events, Change in Disease Activity, and How Oral ABBV-101 Moves Through the Body in Adult Participants With B-Cell Malignancies

NCT05753501

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +31 more
Locations
  • Arizona Oncology - Tucson - Wilmot Road /ID# 252351 Tucson, Arizona, United States
  • UC Irvine Medical Center /ID# 263020 Orange, California, United States
  • Stanford University - Palo Alto /ID# 249683 Palo Alto, California, United States
  • Rocky Mountain Cancer Centers - Lone Tree /ID# 252237 Lone Tree, Colorado, United States
View all 51 locations
View Trial Details
Active, Not Recruiting

A Study of Acalabrutinib vs Investigator's Choice of Idelalisib Plus Rituximab or Bendamustine Plus Rituximab in R/R CLL

NCT02970318

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations
  • Research Site Chandler, Arizona, United States
  • Research Site Oxnard, California, United States
  • Research Site Athens, Georgia, United States
  • Research Site Joliet, Illinois, United States
View all 157 locations
View Trial Details

Related conditions